Back
Sarepta Therapeutics, Inc. Vs. BlueLinx Holdings, Inc. Industry Stock Comparison
Sell
42
SRPT
Sarepta Therapeutics, Inc.
Last Price:
$21.74
Seasonality Move:
10.38%
Buy
51
BXC
BlueLinx Holdings, Inc.
Last Price:
$60.62
Seasonality Move:
23.8%
Sell
42
Sarepta Therapeutics, Inc. (SRPT)
is a Sell
Is Sarepta Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Sarepta Therapeutics, Inc. [SRPT] share price is $21.23. The Score for SRPT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
BlueLinx Holdings, Inc. (BXC)
is a Buy
Is BlueLinx Holdings, Inc. a Buy, Sell or Hold?
-
The current BlueLinx Holdings, Inc. [BXC] share price is $60.87. The Score for BXC is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
BXC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SRPT Stock Price Chart
What is Sarepta Therapeutics, Inc.'s stock price today?
-
The Sarepta Therapeutics, Inc. share price today is $21.23Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight buying pressure.
BXC Stock Price Chart
What is BlueLinx Holdings, Inc.'s stock price today?
-
The BlueLinx Holdings, Inc. share price today is $60.87Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BXC is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.67 | Buy |
| Relative Strength Index (14 RSI): | 52.08 | Buy |
| Chaikin Money Flow: | 241834 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.51 - 22.31) | Buy |
| Bollinger Bands (100): | (17.63 - 22.21) | Buy |
BXC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.23 | Buy |
| Relative Strength Index (14 RSI): | 45.8 | Sell |
| Chaikin Money Flow: | -57962 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.91 - 64.47) | Buy |
| Bollinger Bands (100): | (61.87 - 78.87) | Sell |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.36 | Sell |
| 20-day SMA: | 21.24 | Sell |
| 50-day SMA: | 20.76 | Buy |
| 200-day SMA: | 31.65 | Sell |
| 8-day EMA: | 13.3 | Buy |
| 20-day EMA: | 6.91 | Buy |
| 50-day EMA: | 3.1 | Buy |
| 200-day EMA: | 0.82 | Buy |
BXC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.89 | Sell |
| 20-day SMA: | 62.24 | Sell |
| 50-day SMA: | 63.61 | Sell |
| 200-day SMA: | 72.07 | Sell |
| 8-day EMA: | 62.87 | Sell |
| 20-day EMA: | 62.39 | Sell |
| 50-day EMA: | 64.25 | Sell |
| 200-day EMA: | 74.6 | Sell |
Sarepta Therapeutics, Inc. Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.54 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.05 per share, and an increase next year of $4.83 per share.
BlueLinx Holdings, Inc. Earnings Growth & BXC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.56 per share, a decrease next quarter of $0.00 per share, a decrease this year of $5.29 per share, and an increase next year of $0.86 per share.
Sarepta Therapeutics, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BlueLinx Holdings, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||